Products for Research Use Only
RegisterLogin

Elritercept

CAT: 0804-HY-P990720Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P990720Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Elritercept (KER-050) is a recombinant fusion protein comprising a modified activin receptor type IIA extracellular domain fused to a human IgG1 Fc. Elritercept inhibits activin A and other select TGF-β superfamily ligands[1][2].
CAS Number
2727114-26-1
Product Name Alternative
KER-050
UNSPSC
12352203
Target
TGF-beta/Smad
Type
Inhibitory Antibodies
Related Pathways
Stem Cell/Wnt; TGF-beta/Smad
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/elritercept.html
References & Citations
[1]Elritercept|[2]Lachey J, et al. Elritercept, a modified activin receptor IIA ligand trap, increased erythropoiesis and thrombopoiesis in a phase 1 trial. Blood Adv. 2025 Jan 14;9 (1) :193-201.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
HB949026-01Research Grade Elritercept
E55B1191Elritercept (Reference antibody)
ICH5515-20mgElritercept Biosimilar - Research Grade
GTR18695941-01Elritercept Human Monoclonal Antibody
PX-TA1991-01Elritercept Biosimilar - Anti-ACVR2 fusion protein - Research Grade
A136912Elritercept Biosimilar (Monoclonal, Fusion-[human activin receptor type 2-A (activin receptor type IIA, ACTR-IIA) extracellular domain (ECD) fragment (1-109) engineered varian]2-IgG1-Fc (Fragment constant) )

Popular Products